Conversion-oriented multimodal therapy enabling definitive surgery in a patient with FIGO stage IVA cervical cancer at high risk of fistula formation: a case report - Report - MDSpire
Advertisement
Conversion-oriented multimodal therapy enabling definitive surgery in a patient with FIGO stage IVA cervical cancer at high risk of fistula formation: a case report
Clinical Report: Multimodal Treatment Approach for Stage IVA Cervical Cancer
Overview
This case study presents a successful multimodal treatment strategy for a patient with FIGO stage IVA cervical cancer, highlighting the integration of radiotherapy, targeted therapy, and immunotherapy. The approach facilitated definitive surgery and achieved a pathologic complete response without recurrence during follow-up.
Background
FIGO stage IVA cervical cancer is characterized by extensive pelvic organ invasion, complicating treatment and often leading to severe symptoms. Standard therapies may be ineffective or unsafe in patients with critical organ dysfunction. Innovative treatment strategies that stabilize patients while preparing them for radical surgery are essential for improving outcomes in this high-risk population.
Data Highlights
No numerical data available in the article.
Key Findings
Emergent hemostatic radiotherapy effectively controlled massive vaginal bleeding in the patient.
An individualized multimodal strategy was employed, integrating radiotherapy, targeted therapy, immunotherapy, and consolidation chemotherapy.
Image-guided radiotherapy (IGRT) allowed for adaptive replanning based on tumor regression, minimizing radiation exposure to adjacent organs.
The patient achieved marked tumor regression, enabling definitive radical surgery.
Pathologic complete response was observed with no recurrence during follow-up.
Clinical Implications
This case underscores the potential of a multimodal treatment approach in managing high-risk FIGO stage IVA cervical cancer patients. Clinicians should consider integrating advanced radiotherapy techniques and systemic therapies to optimize treatment outcomes and facilitate surgical interventions.
Conclusion
The findings suggest that a tailored, multidisciplinary strategy can improve the feasibility of radical surgery in complex cases of stage IVA cervical cancer. Further validation through clinical trials is necessary to establish this approach as a standard practice.
